Kirkland Advises on Closing of InTandem Capital Partners Fund III
Kirkland & Ellis advised InTandem Capital Partners, a middle-market private equity firm focused exclusively on healthcare services, on the closing of InTandem Capital Partners Fund III, LP and its parallel fund, with $715 million in total capital commitments. Fund III closed above its original target of $650 million. Fund III will continue InTandem’s strategy of making control investments in North American payor, provider and pharmaceutical services businesses using an operationally intensive, hands-on value creation model.
Read the transaction press release
The Kirkland team was led by investment funds partner Patrick Valenti and associates Christine Lee and Benno Sauermann, with involvement from investment funds partners Jeff Kaplan and Sam Scarcello; regulatory partner John Reinert; and tax partner Phil Cooke.
